What this instrument is
The National Health (Pharmaceutical Benefits-Early Supply) Amendment (August Update) Specification 2026 is a federal instrument registered on 31 July 2026. It amends the existing National Health (Pharmaceutical Benefits-Early Supply) Specification 2026 (PB 32 of 2026).
Enabling legislation and administration
The instrument is made under the National Health Act 1953 and is administered by the Department of Health, Disability and Ageing.
What the source document states about the changes
The source document does not specify what changes were made to the early supply rules, which medicines are affected, or which parties are impacted beyond the PBS framework. The full instrument is available at https://www.legislation.gov.au/F2026L01016.
Finding more detail
- The full text of the instrument is published on the Federal Register of Legislation at https://www.legislation.gov.au/F2026L01016.
- An explanatory statement is linked on that legislation page and provides a plain-language description of what specifically changed in this August update.
- Users of My Account on the Federal Register of Legislation can save this title and set up an alert for future amendments at https://www.legislation.gov.au/F2026L01016.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.